1. Home
  2. LFVN

as of 09-04-2026 10:14am EST

$6.18
+$0.05
+0.75%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

Founded: N/A Country:
United States
United States
Employees: N/A City: LEHI
Market Cap: 78.0M IPO Year: 1996
Target Price: $11.00 AVG Volume (30 days): 48.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
3.56%
Dividend Payout Frequency: semi-annual
EPS: 0.40 EPS Growth: -46.67
52 Week Low/High: $3.90 - $12.10 Next Earning Date: 05-06-2026
Revenue: $203,204,000 Revenue Growth: 1.86%
Revenue Growth (this year): -13.93% Revenue Growth (next year): -0.94%
P/E Ratio: 15.50 Index: N/A
Free Cash Flow: 6.7M FCF Growth: -86.84%

AI-Powered LFVN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 66.30%
66.30%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Lifevantage Corporation (Delaware) (LFVN)

Buy
LFVN Jun 15, 2026

Avg Cost/Share

$8.60

Shares

705

Total Value

$6,059.48

Owned After

137,268

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q2

Q2 2026 Earnings

8-K BUY

Aug 27, 2026 · 100% conf.

AI Prediction BUY

1D

+1.11%

$6.52

Act: -4.88%

5D

+12.96%

$7.29

20D

+21.38%

$7.83

Price: $6.45 Prob +5D: 100% AUC: 1.000
0001193125-26-371265

EX-99.1

2 lfvn-ex99_1.htm

EX-99.1

EX-99.1

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Salt Lake City, UT, August 27, 2026, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.

Fourth Quarter Fiscal 2026 Summary*:

• Revenue was $42.4 million, a decrease of 23.1% from the prior year period;

• Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;

• Net income per diluted share was $0.10, versus $0.15 per diluted share a year ago;

• Adjusted earnings per diluted share was $0.11, compared to $0.17 a year ago; and

• Adjusted EBITDA was $2.7 million compared to $4.8 million a year ago.

* All comparisons are on a year over year basis and compare the fourth quarter of fiscal 2026 to the fourth quarter of fiscal 2025, unless otherwise noted.

Fiscal Year 2026 Summary*:

• Revenue was $182.6 million, a decrease of 20.1% from the prior year period;

• Revenue in the Americas decreased 23.2%, and revenue in Asia/Pacific & Europe decreased 6.9%;

• Net income per diluted share was $0.40, versus $0.75 per diluted share a year ago;

• Adjusted earnings per diluted share was $0.56, compared to $0.82 a year ago; and

• Adjusted EBITDA was $13.7 million compared to $22.1 million a year ago.

* All comparisons are fiscal year 2026 to fiscal year 2025.

"It's a privilege to lead LifeVantage at this stage of its journey and my conviction about this Company is stronger today than when I accepted the role," said Terrence Moorehead, President and Chief Executive Officer. "With a differentiated, science-backed platform, strong gross margins and a debt-free balance sheet, our foundation is strong and I believe we have a real competitive advantage. Our early focus will be on strengthening the LifeVantage brand, building a more relevant consumer proposition, and driving operational excellence. Despite the challenges reflected in our recent results, I'm optimistic about what lies ahead. We intend to move forward with a real sense of urgency and look forward to sharing more about our strategy as our work progresses."

Fourth Quarter Fiscal 2026 Results

For the fourth quarter ended June 30, 2026, the Company reported revenue of $42.4 million, a 23.1% decrease compared to revenue of $55.1 million in the fourth quarter of fiscal 2025. Revenue in the Americas region decreased 24.8% and revenue in the Asia/Pacific & Europe region decreased 16.9%. These decreases were primarily due to due to downward pressure in the number of orders from our active account base and lower average order size, reflecting impacts from the broader macro-economic environment, as well lower sales of our MindBody GLP-1 System cycling the higher comparable fourth quarter of fiscal 2025, partially offset by sales of LoveBiome, which we acquired in October 2025.

Gross profit for the fourth quarter of fiscal 2026 was $33.0 million, or 78.0% of revenue, compared to $44.0 million, or 79.9% of revenue, for the same period in fiscal 2025. The decrease in gross profit as a percentage of revenue was primarily due to a shift in product mix, inventory obsolescence expenses, and increases in shipping related expenses.

Commissions and incentives expense for the fourth quarter of fiscal 2026 was $17.5 million, or 41.3% of revenue, compared to $23.2 million, or 42.1% of revenue, for the same period in fiscal 2025. The decrease in commissions and incentives expenses as a percentage of revenue compared to the prior year period is primarily due to the timing and magnitude of promotional and incentive programs and changes to the sales mix between customers and independent consultants.

Selling, general and administrative (SG&A) expense for the fourth quarter of fiscal 2026 was $13.9 million, or 32.7% of revenue, compared to $18.7 million, or 33.9% of revenue, for the same period in fiscal 2025. The decrease in SG&A expenses as a percentage of revenue was primarily due to decreases in variable employee compensation expenses and lower event related expenses.

Operating income for the fourth quarter of fiscal 2026 was $1.7 million compared to $2.1 million for the same period in fiscal 2025. Adjusted non-GAAP operating income for the fourth quarter of fiscal 2026 was $1.8 million compared to adjusted non-GAAP operating income of $2.5 million for the same period in fiscal 2025.

Net income for the fourth quarter of fiscal 2026 was $1.3 million, or $0.10 per diluted share, compared to $2.0 million, or $0.15 per diluted share for the same period in fiscal 2025. Adjusted non-GAAP net income for the fourth quarter of fiscal 2026 was $1.4 million, or $0.11 per diluted share, compared to adjusted non-GAAP income of $2.3 million, or $0.17 per diluted share, in the same period of fiscal 2025.

Adjusted EBIT

2026
Q1

Q1 2026 Earnings

8-K SELL

May 6, 2026 · 100% conf.

AI Prediction SELL

1D

-8.03%

$5.52

Act: -16.33%

5D

-10.84%

$5.35

Act: -12.17%

20D

-11.51%

$5.31

Act: +55.17%

Price: $6.00 Prob +5D: 0% AUC: 1.000
0001193125-26-208934

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.c706d217.1784333952.ccc6866f

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 4, 2026 · 100% conf.

AI Prediction BUY

1D

+1.11%

$5.61

Act: -16.76%

5D

+12.96%

$6.27

Act: -8.29%

20D

+21.38%

$6.74

Act: -15.32%

Price: $5.55 Prob +5D: 100% AUC: 1.000
0001628280-26-005431

lfvn-202601300000849146false00008491462026-01-302026-01-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2026


LIFEVANTAGE CORPORATION

(Exact name of registrant as specified in its charter)


Delaware001-3564790-0224471 (State or other jurisdiction of incorporation or organization)(Commission File Number)(IRS Employer Identification No.)

3300 Triumph Blvd, Suite 700 Lehi, Utah 84043 (Address of principal executive offices, including zip code) (801) 432-9000 (Registrant's telephone number)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC Title of each classTrading Symbol(s)Name of each exchange on which registered

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.    Results of Operations and Financial Condition. On February 4, 2026, LifeVantage Corporation (the “Company”) issued a press release announcing its financial results for the three and six months ended December 31, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference. The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 30, 2026, Steven R. Fife notified the Company's board of directors (the “Board”) of his decision to retire as President and Chief Executive Officer and from the Board, with such resignation expected to be effective in April 2026. Mr. Fife’s decision to retire is not the result of any disagreement with the Company on any matter relating to the Company's operations, financial policies or practices. More information on Mr. Fife’s retirement can be found in the press release furnished as Exhibit 99.2 to this current report on Form 8-K and incorporated herein by reference. Item 9.01.    Financial Statements and Exhibits. (d)    Exhibits

Exhibit No.Description

99.1Press Release issued by the Company on February 4, 2026, announcing its financial results for the three and six months ended December 31, 2025.

99.2Press Release issued by the Company on February 4, 2026, announcing Mr. Fife's retirement.

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:February 4, 2026By:LIFEVANTAGE CORPORATION

/s/ Carl A. Aure Name:Carl A. Aure Title:Chief Financial Officer

Share on Social Networks: